300+ investors in your industry, stage, and region Get
Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Clean Energy
Photography
Cryptocurrency
Big Data
Email
Artificial Intelligence
Social Impact
CleanTech
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
Retail
InsurTech
Oil and Gas
Film
Marketplace
Payments
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Medical Device
Education
Wellness
Sports
Biotechnology
Automotive
eSports
Legal
Renewable Energy
Software
Crowdfunding
Venture Capital
Recruiting
Web3
Medical
Social
Theatre
Climate
Infrastructure
LGBT
Beauty
Cannabis
Celebrity
Fashion
Life Science
Music
Food and Beverage
Art
Publishing
Mobile Apps
Wine and Spirits
Real Estate
Manufacturing
FinTech
Finance
Sporting Goods
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Proptech
Impact
Enterprise
Sustainability
Hardware
Biotech
Transportation
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Brazil
Oceania
Hong Kong
Nigeria
LATAM
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Poland
Romania
Oman
Puerto Rico
Cameroon
Guernsey
Colombia
Armenia
China
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Panama
Nicaragua
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Botswana
Seychelles
Paraguay
Canada
South Africa
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
India
Germany
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Europe
Qatar
Angola
Cyprus
Argentina
Bangladesh
Barbados
Belgium
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Ecuador
Faroe Islands
Jersey
Bahrain
Ireland
Estonia
Bahamas
Bolivia
Belize
Algeria
Italy
Belarus
Finland
Hungary
Grenada
Israel
Lithuania
Liechtenstein
Honduras
Iceland
Cambodia
Lebanon
Mongolia
Slovenia
Peru
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database

Qingkong Jinxin Blue Microbiology Fund

VC Fund

Qingkong Jinxin Blue Microbiology Fund is a VC fund focused on Robotics and Electronics. Qingkong Jinxin Blue Microbiology Fund

Total investments:
3
Last investment:
Lead investor:
0%

Last updated:

Industries Qingkong Jinxin Blue Microbiology Fund invests in

RoboticsElectronicsHealth CareBiotechnologyManufacturing

Stages Qingkong Jinxin Blue Microbiology Fund invests in

Series A

Countries Qingkong Jinxin Blue Microbiology Fund invests in

China

Investment Focus

Industry

  • Robotics 1 (33%)
  • Electronics 1 (33%)
  • Health Care 1 (33%)
  • Biotechnology 1 (33%)
  • Manufacturing 1 (33%)
See all 6 industries →

Investments

CompanyDescriptionRoundLinks
Robot Era Robot Era
Robot era is an emerging technology business creates embodied intelligence and generic humanoid robot technologies and products. Xingdong Era is committed to the development of universal humanoid robots that can adapt to a wide range of fields, multiple scenarios, and high intelligence, striving to realize the beautiful vision of intelligent robotsentering thousands of households and integrating into the lights of thousands of homes. $69.7M / Series A / Jul 07, 2025
Inspur Health Inspur Health
Inspur Health provides platform for storing medical data. $14.3M / Series A / Feb 18, 2020
Zhiyi Pharmaceutics Zhiyi Pharmaceutics
Founded in 2013, Zhiyi Bio focuses on the research and development of second-generation probiotics and Live Biotherapeutics. Based on the discovery of strains and drug development with independent intellectual property rights, a lot of innovative research has been carried out, and the “Know-How” from strains to drugs has been established, and theinnovative live bacteria drug SK08 is about to enter the clinic. On this basis, Zhiyi will continue to strengthen the research and development of the relationship between human microbiome and disease, including microbial culture group and pathobionts research, target determination and separation of new functional strains. $7.1M / Series A / Sep 05, 2018

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Clean Energy
Photography
Cryptocurrency
Big Data
Email
Artificial Intelligence
Social Impact
CleanTech
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
Retail
InsurTech
Oil and Gas
Film
Marketplace
Payments
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Medical Device
Education
Wellness
Sports
Biotechnology
Automotive
eSports
Legal
Renewable Energy
Software
Crowdfunding
Venture Capital
Recruiting
Web3
Medical
Social
Theatre
Climate
Infrastructure
LGBT
Beauty
Cannabis
Celebrity
Fashion
Life Science
Music
Food and Beverage
Art
Publishing
Mobile Apps
Wine and Spirits
Real Estate
Manufacturing
FinTech
Finance
Sporting Goods
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Proptech
Impact
Enterprise
Sustainability
Hardware
Biotech
Transportation
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Brazil
Oceania
Hong Kong
Nigeria
LATAM
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Poland
Romania
Oman
Puerto Rico
Cameroon
Guernsey
Colombia
Armenia
China
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Panama
Nicaragua
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Botswana
Seychelles
Paraguay
Canada
South Africa
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
India
Germany
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Europe
Qatar
Angola
Cyprus
Argentina
Bangladesh
Barbados
Belgium
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Ecuador
Faroe Islands
Jersey
Bahrain
Ireland
Estonia
Bahamas
Bolivia
Belize
Algeria
Italy
Belarus
Finland
Hungary
Grenada
Israel
Lithuania
Liechtenstein
Honduras
Iceland
Cambodia
Lebanon
Mongolia
Slovenia
Peru
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Qingkong Jinxin Blue Microbiology Fund invest in?

Qingkong Jinxin Blue Microbiology Fund invests primarily in Robotics, Electronics and Health Care startups, most often at Series A stage. Most of the 3 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

When did Qingkong Jinxin Blue Microbiology Fund last invest?

The most recent investment recorded for Qingkong Jinxin Blue Microbiology Fund closed in Jul 2025. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Qingkong Jinxin Blue Microbiology Fund Find emails